These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25669600)

  • 1. Activation contact system (ACS) and tissue factor (TF) in human amniotic fluid: measurements of ACS components and TF, and some implications on the pathophysiology of amniotic fluid embolism.
    Uszyński W; Żekanowska E; Uszyński M; Kieszkowski P
    Thromb Res; 2015 Apr; 135(4):699-702. PubMed ID: 25669600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Contact Activation System (CAS) in cord blood: Measurement of CAS components and comparison with mother's blood. A pilot study.
    Uszyński M; Kuczyński J; Żekanowska E; Uszyński W
    Thromb Res; 2015 Nov; 136(5):1018-21. PubMed ID: 26384441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrinolysis in amniotic fluid: physiology and observations on amniotic fluid embolism, preterm fetal membrane rupture, and pre-eclampsia.
    Uszyński M; Uszyński W
    Semin Thromb Hemost; 2011 Mar; 37(2):165-74. PubMed ID: 21370219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New observations on procoagulant properties of amniotic fluid: microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma.
    Uszyński W; Zekanowska E; Uszyński M; Zyliński A; Kuczyński J
    Thromb Res; 2013; 132(6):757-60. PubMed ID: 24157083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein C, protein S, and thrombomodulin in amniotic fluid. A preliminary study.
    Uszyński M; Zekanowska E; Kotzbach M; Uszyński W; Kotzbach R
    J Perinat Med; 2006; 34(4):289-92. PubMed ID: 16856817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
    Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
    J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of coagulation in amniotic fluid during normal human pregnancy.
    Sarig G; Klil-Drori AJ; Chap-Marshak D; Brenner B; Drugan A
    Thromb Res; 2011 Nov; 128(5):490-5. PubMed ID: 21504838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the protein C system in mother's blood, cord blood and amniotic fluid.
    Uszyński M; Uszyński W; Zekanowska E; Kuczyński J; Szymański M
    Folia Histochem Cytobiol; 2010 Jan; 48(2):262-6. PubMed ID: 20675283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procoagulant activity and phosphatidylserine of amniotic fluid cells.
    Zhou J; Liu S; Ma M; Hou J; Yu H; Lu C; Gilbert GE; Shi J
    Thromb Haemost; 2009 May; 101(5):845-51. PubMed ID: 19404537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J
    Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):163-6. PubMed ID: 11301162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism).
    Levi M
    Thromb Res; 2013 Jan; 131 Suppl 1():S32-4. PubMed ID: 23452737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procoagulant extracellular vesicles in amniotic fluid.
    Hell L; Wisgrill L; Ay C; Spittler A; Schwameis M; Jilma B; Pabinger I; Altevogt P; Thaler J
    Transl Res; 2017 Jun; 184():12-20.e1. PubMed ID: 28236427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amniotic components in the uterine vasculature and their role in amniotic fluid embolism.
    Nakagami H; Kajihara T; Kamei Y; Ishihara O; Kayano H; Sasaki A; Itakura A
    J Obstet Gynaecol Res; 2015 Jun; 41(6):870-5. PubMed ID: 25510819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiological and therapeutic aspects of amniotic fluid embolism (anaphylactoid syndrome of pregnancy): case report with lethal outcome and overview].
    Kretzschmar M; Zahm DM; Remmler K; Pfeiffer L; Victor L; Schirmeister W
    Anaesthesist; 2003 May; 52(5):419-26. PubMed ID: 12750826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic fluid embolism: pathophysiology and new strategies for management.
    Kanayama N; Tamura N
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1507-17. PubMed ID: 24888909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors.
    Park S; Gu JY; Kim HK
    J Thromb Thrombolysis; 2022 Jul; 54(1):11-14. PubMed ID: 34993714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amniotic Fluid Embolism: Anaphylactic Reactions With Idiosyncratic Adverse Response.
    Kobayashi H
    Obstet Gynecol Surv; 2015 Aug; 70(8):511-7. PubMed ID: 26314236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tissue factor pathway in disseminated intravascular coagulation.
    Østerud B; Bjørklid E
    Semin Thromb Hemost; 2001 Dec; 27(6):605-17. PubMed ID: 11740684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.